Group One Trading, L.P. Ultragenyx Pharmaceutical Inc. Transaction History

Group One Trading, L.P.

$2.54 Billion
Q4 2024

A detailed history of Group One Trading, L.P. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 3,610 shares of RARE stock, worth $141,439. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,610

Previous 9,959 63.75%

Holding current value

$141,439

Previous $553,000 72.69%

% of portfolio

0.01%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$42.07 - $57.72 $267,102 - $366,464	-6,349 Reduced 63.75%	3,610 $151,000
Q3 2024 Nov 14, 2024	SELL	$40.21 - $59.36 $20,547 - $30,332	-511 Reduced 4.88%	9,959 $553,000
Q2 2024 Aug 14, 2024	BUY	$37.42 - $51.61 $49,955 - $68,899	1,335 Added 14.61%	10,470 $430,000
Q1 2024 May 10, 2024	BUY	$43.02 - $53.69 $122,650 - $153,070	2,851 Added 45.37%	9,135 $426,000
Q4 2023 Feb 14, 2024	BUY	$31.73 - $49.19 $18,752 - $29,071	591 Added 10.38%	6,284 $300,000
Q3 2023 Nov 09, 2023	BUY	$34.92 - $46.66 $198,799 - $265,635	5,693 New	5,693 $202,000
Q1 2023 May 12, 2023	BUY	$36.99 - $48.71 $319,889 - $421,244	8,648 New	8,648 $346,000
Q1 2022 May 12, 2022	SELL	$62.2 - $84.4 $8,086 - $10,972	-130 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$73.71 - $87.86 $7,370 - $8,786	100 Added 333.33%	130 $11,000
Q3 2021 Nov 12, 2021	SELL	$77.92 - $102.4 $67,868 - $89,190	-871 Reduced 96.67%	30 $3,000
Q2 2021 Aug 10, 2021	BUY	$92.19 - $115.71 $74,120 - $93,030	804 Added 828.87%	901 $86,000
Q1 2021 May 12, 2021	BUY	$106.9 - $167.73 $10,369 - $16,269	97 New	97 $11,000
Q3 2020 Nov 12, 2020	SELL	$72.98 - $90.0 $7,370 - $9,090	-101 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$46.91 - $78.22 $50,522 - $84,242	-1,077 Reduced 91.43%	101 $8,000
Q1 2020 May 13, 2020	BUY	$33.8 - $62.9 $29,574 - $55,037	875 Added 288.78%	1,178 $52,000
Q4 2019 Feb 10, 2020	BUY	$36.08 - $45.83 $9,056 - $11,503	251 Added 482.69%	303 $13,000
Q2 2019 Aug 09, 2019	BUY	$54.93 - $74.36 $2,856 - $3,866	52 New	52 $3,000
Q1 2019 May 13, 2019	SELL	$39.87 - $69.36 $279 - $485	-7 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$38.89 - $77.3 $272 - $541	7 New	7 $0
Q3 2018 Nov 08, 2018	SELL	$71.81 - $90.15 $59,530 - $74,734	-829 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$48.54 - $85.31 $40,239 - $70,721	829 New	829 $64,000

Others Institutions Holding RARE

# of Institutions

345

Shares Held

86.7M

Call Options Held

675K

Put Options Held

846K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.74B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Ultragenyx Pharmaceutical Inc. Transaction History